Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07832123 |
| Title | Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II Study (SAFU-G3) |
| Acronym | SAFU-G3 |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University of Zurich |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University Hospital Zürich | Zurich | Canton of Zurich | Switzerland | Details |